David Dodwell
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Global Cancer Incidence and Screening, Breast Lesions and Carcinomas, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer(2004)1,763 cited
- → Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials(2017)1,112 cited
- → Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial(2007)908 cited
- → Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials(2017)768 cited
- → Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study(2005)664 cited
- → Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials(2019)385 cited
- → Addressing overtreatment of screen detected DCIS; the LORIS trial(2015)369 cited
- → Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials(2021)332 cited
- → Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial(2014)291 cited